These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 16906689)
1. Biopure moves to sell blood substitute in Europe. Burton TM Wall St J (East Ed); 2006 Jul; ():D2. PubMed ID: 16906689 [No Abstract] [Full Text] [Related]
2. Blood-substitute study is criticized by U.S. agency. Burton TM Wall St J (East Ed); 2006 Mar; ():A3. PubMed ID: 16578912 [No Abstract] [Full Text] [Related]
3. Pharmaceutical marketing in a new age. Effective campaigns still need to focus on what customers want. Rao SK Mark Health Serv; 2002; 22(1):6-12. PubMed ID: 11881547 [TBL] [Abstract][Full Text] [Related]
4. A brand new bag. Trauma-care revolution among benefits touted as blood substitute enters critical phase of clinical trials. Becker C Mod Healthc; 2004 Apr; 34(15):30-1, 34. PubMed ID: 15124419 [No Abstract] [Full Text] [Related]
5. Implications of FDA's proposal to include foreign marketing experience in the over-the-counter drug review process. Pinco RG Food Drug Law J; 1998; 53(1):105-22. PubMed ID: 11795327 [No Abstract] [Full Text] [Related]
6. The ODAC Chronicles: Part 3. The FDA's philosophy and process for cancer drug evaluation and approval. Grillo-López AJ Expert Rev Anticancer Ther; 2005 Feb; 5(1):1-5. PubMed ID: 15757431 [No Abstract] [Full Text] [Related]
7. Need a new drug? Gorman C Time; 1995 Jul; 146(5):52. PubMed ID: 10144386 [No Abstract] [Full Text] [Related]
8. FDA to weigh test of blood substitute out of public view. Burton T Wall St J (East Ed); 2006 Jul; ():D3. PubMed ID: 16906688 [No Abstract] [Full Text] [Related]
9. Potential pathways for abbreviated approval of generic biologics under existing law and proposed reforms to the law. Dinh TQ Food Drug Law J; 2007; 62(1):77-137. PubMed ID: 17444027 [No Abstract] [Full Text] [Related]
12. Baxter's blood substitute OK'd for trauma testing. Hensley S Mod Healthc; 1996 Dec; 26(49):16. PubMed ID: 10162699 [No Abstract] [Full Text] [Related]
13. Amid alarm bells, a blood substitute keeps pumping; ten in trial have heart attacks, but data aren't published; FDA allows a new study; doctors' pleas are ignored. Burton TM Wall St J (East Ed); 2006 Feb; ():A1, A12. PubMed ID: 16528878 [No Abstract] [Full Text] [Related]
14. Ethical considerations concerning South Africa's approval of a blood substitute. Schutte AE Ethics Med; 2002; 18(2):55-62. PubMed ID: 14700041 [No Abstract] [Full Text] [Related]
15. Not blood simple. Stokstad E Science; 2002 Feb; 295(5557):1003. PubMed ID: 11834812 [No Abstract] [Full Text] [Related]
16. The Orphan Drug Act: an engine of innovation? At what cost? Rohde DD Food Drug Law J; 2000; 55(1):125-43. PubMed ID: 12322720 [No Abstract] [Full Text] [Related]
17. Herbal Rx: the promises and pitfalls. Consum Rep; 1999 Mar; 64(3):44-8. PubMed ID: 10557627 [No Abstract] [Full Text] [Related]
18. The Minor Use and Minor Species Animal Health Act: past, present, and future. Haley CJ Food Drug Law J; 2006; 61(1):13-43. PubMed ID: 16838456 [No Abstract] [Full Text] [Related]
19. When a long shot is worth a shot. Jacobs T; Fischer J Nat Biotechnol; 2005 Jul; 23(7):805. PubMed ID: 16003361 [No Abstract] [Full Text] [Related]
20. FDA to weigh using fake blood in trauma trial. Burton TM Wall St J (East Ed); 2006 Jul; ():B1, B2. PubMed ID: 16909496 [No Abstract] [Full Text] [Related] [Next] [New Search]